Incyte Corporation (INCY)
US$ 58.98-1.26%
Price Chart
Key Statistics
Market Cap
$ 13.28B
P/E Ratio
342.95
Revenue (TTM)
$ 4.41B
Volume
1.23M
52W High
$ 83.95
52W Low
$ 53.56
Dividend Yield
0.00%
Beta
0.68
Technicals
50-Day MA
65.951
200-Day MA
68.0418
52 Week High
83.95
52 Week Low
53.56
About INCY
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI.
Employees
2617
Headquarters
Wilmington, DE
CEO
Dr. Steven H. Stein M.D.
Latest News
High Growth Tech Stocks To Watch In US July 2025 - simplywall.st
22 hours ago • Google News
Insider Sale: EVP of $INCY Sells 2,682 Shares - Quiver Quantitative
4 days ago • Google News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
29.4
Percentile: 47.86
Environmental Risk Score
7.61
Percentile: 8
Social Risk Score
24.73
Percentile: 8
Governance Risk Score
12.56
Percentile: 8
Controversy Level
ESG data provided by Sustainalytics, Inc.
INCY
Category Average
1Low Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg